Fig 1: NETs augment HUVECs thrombogenicity. (a) Representative confocal microscopy images showed that treatment of HUVECs with NETs (0.5 μg DNA/mL) for 24 h led to the retraction of cell margins, the extension of filopodia (arrows), and TF (red) were dotted on the surface and filopodia of HUVECs (arrowheads). HUVECs were incubated with lactadherin (green) and PI (red). HUVECs exhibited irregular morphology and formed pseudopodia with strong green fluorescence stained by lactadherin (arrows). Kinetics of TF (b) and PS (c) exposure on HUVECs incubated with NETs (0.5 μg DNA/mL) and in the presence of inhibitors. (d) FVa and FXa colocalisation (yellow) is observed on filopodia (arrows) near the retracted edges of HUVECs. HUVECs pretreated with NETs and incubated with healthy plasma showed considerable fibrin strand formation arranged radially along with filopodia (arrows) to form a fibrin network. (e) Intrinsic Xa, extrinsic Xa, and thrombin production were measured on HUVECs treated with various concentrations of NETs. (f) Inhibition assays of protein production were performed using sivelestat, anti-MMP9 antibody, or APC to degrade NET-associated elastase or histones before incubation with HUVECs. (g) Fibrin formation of HUVECs stimulated with various concentrations of NETs for 24 h in the presence of sivelestat, anti-MMP9 antibody, or APC was measured. Each point represents mean ± SD. Scale bar: 5 μm. One of six (a and d) independent experiments is shown. Statistics, one-way ANOVA or Student's t-test. *P < 0.05 versus control, #P < 0.05 versus NETs (0.5 μg DNA/mL) group in (b) *P < 0.001 versus control groups; #P < 0.05, ##P < 0.01 versus NETs groups in (c). **P < 0.01 versus control or NETs groups (0.1 μg DNA/mL) in (e) and (g). *P < 0.05, **P < 0.01 versus NETs groups in (f). #P < 0.05, ##P < 0.01 versus sivelestat (-) anti-MMP9 antibody (-) APC (-) groups in (g). For (b) (c) (e) (f) (g) n = 8. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Supplier Page from Abcam for Anti-Factor X antibody